Literature DB >> 6799415

Concentrations of antimicrobial agents in middle ear fluid, saliva and tears.

J D Nelson, C M Ginsburg, O Mcleland, J Clahsen, M C Culbertson, H Carder.   

Abstract

Antibiotics concentrations in middle ear fluid (MEF), saliva and tears were measured in children with persistent middle ear effusions undergoing tympanostomy tube placement. In 31 children given cefaclor, specimens of serum, saliva and MEF were collected at 0.5, 1, 2, 3 or 5 h after a dose. Another group of 37 children were randomized to receive a single dose of penicillin V, amoxicillin, ampicillin, erythromycin estolate, erythromycin ethylsuccinate, trimethoprim-sulfamethoxazole or cefaclor. Concentrations of antibiotics in saliva and tears bore no consistent relationship to those in MEF. Mean concentrations of all drugs in MEF were several-fold greater than the usual minimal inhibitory concentrations (MIC) of pneumococci, but only with trimethoprim and cefaclor were they greater than in usual MIC's for Haemophilus influenzae. Concentrations of antibiotics in MEF in persistent effusions were comparable to those previously reported in acute purulent effusions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6799415     DOI: 10.1016/0165-5876(81)90057-4

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  8 in total

1.  Effect of amoxicillin use on oral microbiota in young children.

Authors:  D Ready; H Lancaster; F Qureshi; R Bedi; P Mullany; M Wilson
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  Loracarbef concentrations in middle ear fluid.

Authors:  H Kusmiesz; S Shelton; O Brown; S Manning; J D Nelson
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

Review 3.  Variations in amoxicillin pharmacokinetic/pharmacodynamic parameters may explain treatment failures in acute otitis media.

Authors:  Michael E Pichichero; Michael D Reed
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

4.  Penetration of ceftibuten into middle ear fluid.

Authors:  C Lin; P Kumari; R J Perrotta; B E Reidenberg
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

5.  Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.

Authors:  D M Cappelletty; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

6.  In vitro activity of orally administered antimicrobial agents against Haemophilus influenzae recovered from children monitored longitudinally in a group day-care center.

Authors:  M J George; B Kitch; F W Henderson; P H Gilligan
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

7.  Penetration of cefprozil into middle ear fluid of patients with otitis media.

Authors:  W C Shyu; J Haddad; J Reilly; W N Khan; D A Campbell; Y Tsai; R H Barbhaiya
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

8.  In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; A W Howell
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.